Project ENTenna – Asia’s First Allergy Database, Led by Our JHC Team!
NTFGH is proud to launch Project ENTenna — a groundbreaking initiative to tackle allergic rhinitis, a condition that affects nearly 4 in 10 Singaporeans.
By 2026, ENTenna aims to recruit 6,000 patients to build Asia’s first large-scale allergy database for allergic rhinitis. Leveraging AI-powered tools, our team will transform how we understand, manage, and prevent this common condition.

Supported by NUH, TTSH, CGH, and A*Star—and funded by the Ministry of Health’s Health Innovation Fund and the JurongHealth Fund — this collaboration exemplifies the power of collective expertise and strategic partnerships.
At the heart of the project is NTFGH’s Department of Otolaryngology – Head & Neck Surgery (ENT). Adjunct A/Prof Ng Chew Lip, Senior Consultant and Principal Investigator, leads the overall study, driving research into how genetic differences in Asian populations influence treatment outcomes. He is supported by a dedicated NTFGH research team, working alongside partners to design the patient recruitment process, manage clinical data, and integrate AI-enabled tools into everyday care.
Co-Principal Investigator Dr Tan Jian Li, Consultant, Department of Otorhinolaryngology, Tan Tock Seng Hospital, is leading efforts to extend ENTenna’s AI-powered tools and WhatsApp chatbot to other chronic conditions. Meanwhile, Dr Oh Hong Choon, Deputy Director, Health Services Research Department, Changi General Hospital, spearheads the data analytics to enable proactive care and early interventions.

With over 2,000 participants already onboard, Project ENTenna is proof that innovation, teamwork, and compassion can elevate care for our community. As the first in Asia to embark on such an ambitious effort, NTFGH and our partners are setting new benchmarks for smarter, personalised healthcare.
We are immensely proud of our dedicated staff, whose tireless efforts drive innovation and enhance patient care. Together, we are shaping the future of patient-centred healthcare—today and tomorrow.

For the full article and more details, please refer to The Straits Times coverage here.

